Octapharma Ab

Company-provided description, not an official-source fact. Certifications, capacities, years and market positions stated in it are the company's own claims until a record below confirms them.

브라질 보건 규제 기관인 ANVISA는 2027년 11월 20일까지 유효한 생물학적 활성 제약 성분을 다루는 이 식물에 대한 유효한 우수 제조 관리 기준 인증서를 보유하고 있습니다. 인증서는 공장 자체를 검사한 후에 발급되므로 외국 규제 기관에서 이 사이트를 명명합니다. 여기서 생산된 제품은 브라질 시장에서 허용됩니다. 프로세스 번호 25351544837201689.

Type
manufacturer (our classification of the record, not a statement by the company)
Role
Manufacturer (official record)
Location
Sweden
Categories
의약품 제조
Markets
스웨덴, 브라질

Listed in a source registry

ANVISA (Brazilian Health Regulatory Agency) open data

What is established and what is not

No researcher review has been written for this company yet. 10 official records from 10 official sources are on file. 2 other entries are not official records: our own technical checks and searches, open directory listings, our inferences or the company's own statements. Everything is listed below with its evidence type: each entry confirms only what it literally says; none of them is a review. The manufacturing role above rests on the official records listed below, and only as far as each literally goes: a facility registration or licence is not an observation of current production. Nothing here confirms ownership or trading status beyond what each record literally says.

Facts on file, each with its evidence type

Import rules for these goods

Check independently

Full page for humans